Evidence map›Paper›PMID 41516405›Full record

ArticleInternational journal of molecular sciences2026

Genetic Evolution of Melanoma: Comparative Analysis of Candidate Gene Mutations in Healthy Skin, Nevi, and Tumors from the Same Patients.

Marta Gil-Barrachina, Barbara Hernando, Gemma Perez-Pastor, Victor Alegre-de-Miquel, Cristian Valenzuela-Oñate, Sandra Minguez-Lujan, Pablo Monfort-Lanzas, Elena Tomas-Bort, Maria Angeles Marques-Torrejon, Conrado Martinez-Cadenas

Abstract readComparative Study
In one paragraph

Article in International journal of molecular sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Marta Gil-BarrachinaDepartment of Medicine, Jaume I University of Castellon, 12071 Castellon, Spain.ORCID 0000-0001-7983-7628
Barbara HernandoSpanish National Cancer Research Centre (CNIO), 28029 Madrid, Spain.
Gemma Perez-PastorDepartment of Dermatology, Consorcio Hospital General Universitario de Valencia, 46014 Valencia, Spain.ORCID 0000-0002-5090-1531
Victor Alegre-de-MiquelDepartment of Dermatology, Consorcio Hospital General Universitario de Valencia, 46014 Valencia, Spain.
Cristian Valenzuela-OñateDepartment of Dermatology, Consorcio Hospital General Universitario de Valencia, 46014 Valencia, Spain.
Sandra Minguez-LujanDepartment of Dermatology, Consorcio Hospital General Universitario de Valencia, 46014 Valencia, Spain.
Pablo Monfort-LanzasInstitute of Medical Biochemistry, Medical University of Innsbruck, 6020 Innsbruck, Austria.ORCID 0000-0003-2589-3960
Elena Tomas-BortCentre of Technology and Bioinformatics Millars, 12550 Almazora, Spain.
Maria Angeles Marques-TorrejonDepartment of Medicine, Jaume I University of Castellon, 12071 Castellon, Spain.ORCID 0000-0001-5725-5774
Conrado Martinez-CadenasDepartment of Medicine, Jaume I University of Castellon, 12071 Castellon, Spain.ORCID 0000-0002-5252-563X

Funding

Universitat Jaume I 20I463 - UJI-B2020-11
6 · The paper itself

Abstract

Melanocytic tumorigenesis is thought to occur through stepwise genomic evolution from normal skin to nevi and, ultimately, melanoma. To investigate this progression, we performed targeted deep sequencing of a 46-gene panel in matched healthy skin, nevus, and melanoma samples from 15 patients, including 14 complete tissue trios. Mutation burden increased progressively across tissues, with median mutation counts rising from benign skin to nevi and showing the highest levels in melanoma, consistent with cumulative somatic alterations. Canonical MAPK pathway mutations were common:

Indexed as

Evolution, MolecularMelanomaMutationNevusSkinSkin NeoplasmsFemaleGene FrequencyHumansMaleclonal progressiondriver genesmelanomamelanoma evolutionnevussomatic mutation

Identifiers

PMID41516405
PMCPMC12786832

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.